Published in PLoS Med on February 07, 2012
Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med (2013) 6.58
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open (2012) 3.93
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog (2012) 3.81
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol (2012) 2.04
Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis (2013) 1.58
Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence. Clin Infect Dis (2015) 1.45
Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant. Infect Control Hosp Epidemiol (2015) 1.41
Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission. PLoS Comput Biol (2013) 1.38
Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol (2015) 1.29
Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis (2014) 1.28
Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One (2014) 1.14
A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe (2012) 1.10
Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One (2013) 1.07
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol (2016) 1.03
Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol (2013) 1.01
Clostridium: transmission difficile? PLoS Med (2012) 0.97
Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. BMC Infect Dis (2013) 0.96
Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model. Sci Rep (2015) 0.96
Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev (2015) 0.94
Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genomics (2014) 0.93
Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients. Antimicrob Agents Chemother (2015) 0.91
Modelling the transmission of healthcare associated infections: a systematic review. BMC Infect Dis (2013) 0.88
Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease. J Clin Microbiol (2013) 0.86
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection. J Antimicrob Chemother (2014) 0.86
WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg (2015) 0.85
Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease. PLoS One (2013) 0.84
Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review. PLoS One (2013) 0.83
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis (2015) 0.82
Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors. PLoS One (2015) 0.79
The association of hospital prevention processes and patient risk factors with the risk of Clostridium difficile infection: a population-based cohort study. BMJ Qual Saf (2015) 0.79
Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile. PLoS Med (2012) 0.78
Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection. J Clin Microbiol (2013) 0.78
A comparison of Clostridium difficile ribotypes circulating in Australian hospitals and communities. J Clin Microbiol (2016) 0.77
Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile. Infect Dis Ther (2014) 0.75
Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings. Emerg Infect Dis (2016) 0.75
A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar. J Clin Microbiol (2013) 0.75
Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infection. PLoS One (2014) 0.75
Community-Acquired Clostridium difficile Infection, Queensland, Australia. Emerg Infect Dis (2016) 0.75
Estimating risk of C. difficile transmission from PCR positive but cytotoxin negative cases. PLoS One (2014) 0.75
An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients. Infect Control Hosp Epidemiol (2016) 0.75
Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains. PLoS One (2017) 0.75
Development and evaluation of double locus sequence typing for molecular epidemiological investigations of Clostridium difficile. Eur J Clin Microbiol Infect Dis (2015) 0.75
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med (2000) 6.24
Inoculation syphilis in human volunteers. Medicine (Baltimore) (1956) 6.18
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis (2007) 4.77
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis (2008) 4.07
Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet (1998) 3.29
Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect (2011) 3.24
Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol (2009) 3.18
Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis (2007) 2.90
Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29
Laboratory diagnosis of Clostridium difficile infection: in a state of transition or confusion or both? J Hosp Infect (2011) 2.11
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis (2010) 1.97
Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis (2007) 1.87
How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med (2005) 1.87
Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies. J Med Microbiol (2005) 1.78
Incubation period of AIDS in patients infected via blood transfusion. Nature (1987) 1.71
The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis (2010) 1.70
Clostridium difficile mixed infection and reinfection. J Clin Microbiol (2011) 1.59
Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis (2009) 1.55
Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J Clin Microbiol (2009) 1.48
Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol (2010) 1.41
Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol (2005) 1.36
Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens. J Clin Microbiol (2010) 1.23
Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. Am J Epidemiol (1992) 1.22
Defining criteria to interpret multilocus variable-number tandem repeat analysis to aid Clostridium difficile outbreak investigation. J Med Microbiol (2011) 1.03
How infections propagate after point-source outbreaks: an analysis of secondary norovirus transmission. Epidemiology (2010) 0.99
Role of antibody response in outcome of antibiotic-associated diarrhoea. Lancet (2001) 0.90
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis (2012) 7.18
Clostridium difficile infection in Europe: a hospital-based survey. Lancet (2011) 6.25
Multilocus sequence typing system for group B streptococcus. J Clin Microbiol (2003) 6.22
Contingency management for treatment of substance use disorders: a meta-analysis. Addiction (2006) 6.18
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis (2003) 5.73
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis (2008) 3.98
Comparative genotyping of Campylobacter jejuni by amplified fragment length polymorphism, multilocus sequence typing, and short repeat sequencing: strain diversity, host range, and recombination. J Clin Microbiol (2003) 3.97
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open (2012) 3.93
Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev (2008) 3.80
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis (2012) 3.71
Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog (2007) 3.65
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis (2013) 3.56
Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis (2004) 3.31
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis (2013) 3.15
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clin Infect Dis (2013) 3.05
Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem (2004) 2.91
MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 2.87
MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. BMJ (2005) 2.77
Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis (2006) 2.54
Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ (2006) 2.37
Host-associated genetic import in Campylobacter jejuni. Emerg Infect Dis (2007) 2.28
Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ (2007) 2.19
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun (2011) 2.11
Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol (2007) 2.06
Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One (2011) 2.04
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol (2012) 2.04
Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ (2012) 1.93
Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J Bacteriol (2004) 1.93
Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother (2008) 1.91
Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis (2007) 1.84
Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol (2004) 1.83
Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol (2003) 1.78
Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence. Cell Microbiol (2008) 1.78
Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet (2006) 1.74
Molecular analysis of the beta-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the beta(S) Senegal mutation. Am J Hum Genet (2001) 1.73
The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis (2010) 1.70
Hybrid Vibrio vulnificus. Emerg Infect Dis (2005) 1.68
Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One (2013) 1.67
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother (2010) 1.67
Novel type IV secretion system involved in propagation of genomic islands. J Bacteriol (2006) 1.64
Molecular evidence for dissemination of unique Campylobacter jejuni clones in Curaçao, Netherlands Antilles. J Clin Microbiol (2003) 1.64
Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study. Arch Dis Child (2007) 1.60
Clostridium difficile mixed infection and reinfection. J Clin Microbiol (2011) 1.59
Application of coalescent methods to reveal fine-scale rate variation and recombination hotspots. Genetics (2004) 1.59
Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol (2009) 1.57
CD8+ T effector memory cells protect against liver-stage malaria. J Immunol (2011) 1.55
Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun (2005) 1.53
Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis (2012) 1.51
Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. Clin Infect Dis (2006) 1.47